基本信息
浏览量:0
职业迁徙
个人简介
Grants
Deciphering the role of noncoding variation in the pathogenesis of multiple sclerosis awarded by National Institutes of Health 2021 - 2026
ECHO MS awarded by National Multiple Sclerosis Society 2023 - 2024
ECHO MS 2020 awarded by National Multiple Sclerosis Society 2020 - 2022
PA Fellowship in Clinical Neuroimmunology awarded by Biogen, Inc. 2017 - 2019
An Escalating Multiple Dose Study of ABT-555 in Subjects with Relapsing Forms of Multiple Sclerosis awarded by AbbVie Inc. 2017 - 2018
Susceptibility MRI as a marker for diagnosis and clinical disability in MS awarded by National Institutes of Health 2014 - 2017
A Phase II, multicenter, randomized, double-blind, parallel gruop, placebo-controlled, adaptive dose-ranging study to eveluate the efficacy and safety of AIN457 (Secuinumab) (IV) inn patients with relapsing mutiple sclerosis. awarded by Novartis Pharmaceuticals Corporation 2013 - 2016
Defining the Functional Role of a Novel MS Susceptibility Gene, IL7R alpha chain awarded by National Institutes of Health 2009 - 2015
Topic Briefs TO#4_Disease Modifying Therapies on Multiple Sclerosis awarded by Patient Centered Outcomes Research Institute 2015 - 2015
Criterial to Determine Disability Related to Multiple Sclerosis awarded by Agency for Healthcare Research and Quality 2002 - 2004
Deciphering the role of noncoding variation in the pathogenesis of multiple sclerosis awarded by National Institutes of Health 2021 - 2026
ECHO MS awarded by National Multiple Sclerosis Society 2023 - 2024
ECHO MS 2020 awarded by National Multiple Sclerosis Society 2020 - 2022
PA Fellowship in Clinical Neuroimmunology awarded by Biogen, Inc. 2017 - 2019
An Escalating Multiple Dose Study of ABT-555 in Subjects with Relapsing Forms of Multiple Sclerosis awarded by AbbVie Inc. 2017 - 2018
Susceptibility MRI as a marker for diagnosis and clinical disability in MS awarded by National Institutes of Health 2014 - 2017
A Phase II, multicenter, randomized, double-blind, parallel gruop, placebo-controlled, adaptive dose-ranging study to eveluate the efficacy and safety of AIN457 (Secuinumab) (IV) inn patients with relapsing mutiple sclerosis. awarded by Novartis Pharmaceuticals Corporation 2013 - 2016
Defining the Functional Role of a Novel MS Susceptibility Gene, IL7R alpha chain awarded by National Institutes of Health 2009 - 2015
Topic Briefs TO#4_Disease Modifying Therapies on Multiple Sclerosis awarded by Patient Centered Outcomes Research Institute 2015 - 2015
Criterial to Determine Disability Related to Multiple Sclerosis awarded by Agency for Healthcare Research and Quality 2002 - 2004
研究兴趣
论文共 5 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Trisha Dalapati,Gregg Robbins-Welty, Rick P F Wolthusen, Lynette Staplefoote-Boynton, Andres Diocares,Mark B Skeen,Jane P Gagliardi
The primary care companion for CNS disordersno. 5 (2023)
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn